<!DOCTYPE html>
<html>
<head>
    <title>BREAKING: Federal Register: Notice of Opportunity for Public Comment on Proposal To Withdraw Approval of New Drug Application for PEPAXTO, Equivalent to 20 Milligrams Base per Vial</title>
    <meta charset="UTF-8">
    <style>
        body { font-family: Georgia, serif; max-width: 800px; margin: 0 auto; padding: 20px; }
        h1 { border-bottom: 2px solid #333; }
        .breaking { background: #fff3cd; border-left: 4px solid #dc3545; padding: 15px; }
        .source { background: #f8f9fa; padding: 10px; margin-top: 20px; font-size: 0.9em; }
        .timestamp { color: #666; }
    </style>
</head>
<body>
    <h1>BREAKING: Federal Register: Notice of Opportunity for Public Comment on Proposal To Withdraw Approval of New Drug Application for PEPAXTO, Equivalent to 20 Milligrams Base per Vial</h1>
    <p class="timestamp">Published: 2023-08-25 | Source: Federal Register</p>
    <div class="breaking">
        <p><strong>The Center for Drug Evaluation and Research (CDER) of the Food and Drug Administration (FDA, the Agency) is proposing to withdraw approval of PEPAXTO (melphalan flufenamide) for injection, equivalent to (EQ) 20 milligrams (mg) BASE/VIAL, once every 28 days, new drug application (NDA) 214383, held by Oncopeptides AB (Oncopeptides). This notice is intended to provide an opportunity for public comment on CDER's proposed withdrawal of PEPAXTO, in accordance with the expedited withdrawal of approval ...</strong></p>
    </div>
    <h2>Document Details</h2>
    <p><strong>Document Type:</strong> Notice</p>
    <p><strong>Agency:</strong> Health and Human Services Department, Food and Drug Administration</p>
    <p><strong>Document Number:</strong> 2023-18320</p>
    <p><strong>Publication Date:</strong> 2023-08-25</p>
    <h2>Official Source</h2>
    <p>Read the full document at: <a href="https://www.federalregister.gov/documents/2023/08/25/2023-18320/notice-of-opportunity-for-public-comment-on-proposal-to-withdraw-approval-of-new-drug-application">https://www.federalregister.gov/documents/2023/08/25/2023-18320/notice-of-opportunity-for-public-comment-on-proposal-to-withdraw-approval-of-new-drug-application</a></p>
    <div class="source"><strong>Source:</strong> Federal Register - 2023-18320</div>
    <p><a href="index.html">Back to Breaking News Wire</a></p>
</body>
</html>
